期刊文献+

非霍奇金淋巴瘤患者自体外周血造血干细胞动员采集的影响因素分析

Influencing factors of autologous peripheral blood hematopoietic stem cell mobilization and collection in patients with non-Hodgkin's lymphoma
下载PDF
导出
摘要 目的:分析非霍奇金淋巴瘤患者自体外周血造血干细胞动员采集的影响因素。方法:收集西安交通大学第一附属医院血液内科2011年1月至2020年6月共计85例行自体外周血造血干细胞动员采集的非霍奇金淋巴瘤患者临床资料。采用单因素和多因素分析性别、年龄、疾病分型、Ann Arbor分期、移植前状态、国际预后指数评分、动员前化疗次数及动员方案对造血干细胞采集效果的影响。结果:单因素分析发现患者年龄、疾病分型、分期、动员前状态与动员采集CD34^(+)细胞数、动员采集成功率无相关性(P>0.05);男性患者CD34^(+)细胞数多于女性(P=0.01);动员前化疗周期≤4次是采集的有利因素(P<0.05);CHOP-E及CHOP-MTX联合G-CSF动员方案均可作为自体外周血造血干细胞有效的动员方案。多因素结果显示采集前化疗周期数是影响造血干细胞采集成功的独立因素,动员前化疗周期>4次是造血干细胞能否采集成功的不良因素。结论:CHOP-MTX+G-CSF动员方案比较CHOP-E+G-CSF采集CD34^(+)细胞数更多。男性患者、动员采集前化疗周期数较少时更有利于NHL患者自体外周血造血干细胞动员采集。 Objective:To determine the factors affecting the mobilization and collection of autologous peripheral blood hematopoietic stem cells(APBSC)in patients with non-Hodgkin's lymphoma(NHL).Methods:The clinical data of 85 NHL patients who received the mobilization and collection of APBSC in the Department of Hematology of the First Affiliated Hospital of Xi'an Jiaotong University from January 2011 to June 2020 were collected.The effects of gender,age,disease type,Ann Arbor stage,pre-transplant disease status,International Prognostic Index(IPI)score,chemotherapy cycle,and different schemes on APBSC collection were analyzed by univariate and multivariate Logisitic regression.Results:Univariate analysis showed that there was no correlation between the age,disease type,Ann Arbor stage,disease status and the number of CD34^(+)cells collected or the collection success rate(P>0.05).Male patients had more CD34^(+)cells than female patients(P=0.01).Chemotherapy cycles≤4 times before mobilization were favorable factors for collection(P<0.05).CHOP-E and CHOP-MTX combined with G-CSF mobilization schemes could be used as effective mobilization schemes for APBSC.Multivariate results showed that the number of chemotherapy cycles before collection was an independent factor affecting the success of hematopoietic stem cell collection,and the number of chemotherapy cycles>4 times before mobilization was a negative factor for the success of hematopoietic stem cell collection.Conclusion:Compared with CHOP-E+G-CSF,CHOP-MTX+G-CSF mobilized more CD34^(+)cells.Male patients and those with fewer chemotherapy cycles before mobilization collection are more conducive to the mobilization and collection of autologous peripheral blood hematopoietic stem cells in NHL patients.
作者 梁霄 仙木斯亚·买买提热夏提 郑晓燕 王晓宁 闻淑娟 LIANG Xiao;Xianmusiya·Maimaitirexiati;ZHENG Xiaoyan;WANG Xiaoning;WEN Shujuan(Department of Lymphoma,the Affiliated Tumor Hospital of Xinjiang Medical University,Xinjiang Urumqi 830011,China;Department of Hematology,the First Affiliated Hospital of Xi'an Jiaotong University,Shaanxi Xi'an 710061,China)
出处 《现代肿瘤医学》 CAS 2024年第2期304-308,共5页 Journal of Modern Oncology
基金 新疆维吾尔自治区自然科学基金项目(编号:2021D01C416) 自治区科技支疆项目计划(指令性)项目(编号:2022E02053)。
关键词 非霍奇金淋巴瘤 自体造血干细胞移植 干细胞动员采集 non-Hodgkin's lymphoma autologous peripheral blood stem cell transplantation stem cell mobilization and collection
  • 相关文献

参考文献10

二级参考文献58

  • 1栾佐.儿童恶性淋巴瘤的诊断与治疗[J].实用儿科临床杂志,2005,20(1):1-2. 被引量:15
  • 2唐暐,胡炯,赵维莅,朱莉萍,徐岚,吴文,阎骅,沈志祥.造血干细胞动员及采集的影响因素[J].上海交通大学学报(医学版),2007,27(9):1139-1141. 被引量:5
  • 3Rajkumar SV. Treatment of multiple myeloma [J]. Nat Rev Clin Oncol, 2011, 8(8):479-491.
  • 4Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma [J]. Leukemia, 2009, 23 ( 1 ):3-9.
  • 5Greipp PR, San Mignel J, Durie BG, et al. International staging system for multiple myeloma [J]. J Clin Oncol, 2005, 23 (15): 3412-3420.
  • 6Wuchter P, Ran D, Bruckner T, et al. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of antologous transplantation[J]. Biol Blood Marrow Transplant, 2010, 16(4):490-499.
  • 7Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral- blood stem cells[J]. J Clin Oncol, 1995, 13( 10):2547-2555.
  • 8Stiff P J, Micallef I, Nademanee AP, et al. Transplanted CD34 (+) cell dose is associated with long-term platelet count recov- ery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma [J]. Biol Blood Marrow Transplant, 2011, 17 ( 8 ): 1146-1153.
  • 9Duong HK, Savani BN, Copelan E, et al. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation [J]. Biol Blood Marrow Transplant, 2014, 20(9): 1262-1273.
  • 10Cavo M, Rajkumar SV, Palumbo A, et al. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation[J]. Blood, 2011, 117(23):6063-6073.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部